Is Pfizer Stock A Buy After The FDA Approved Its Updated Covid Shot?

Is Pfizer Stock A Buy After The FDA Approved Its Updated Covid Shot?

Upworthy

Published

The Food and Drug Administration signed off on Pfizer's (PFE) BioNTech (BNTX)-partnered Covid booster in mid-September, but Pfizer stock remains below its 50-day moving average. The vaccine blocks the XBB.1.5 subvariant of omicron. Today, that strain accounts for only 3% of all sequenced Covid…

#pfizer #pfe #bntxpartneredcovid #fda #moderna #spikevax #novonordisk #nvo #elililly #lly

Full Article